Pharmafile.com’s weekly COVID-19 news round-up
May 12, 2021Research and Development COVID-19
The past week has seen India’s highest number of COVID-19 deaths, with 4,205 fatalities in a single day. There has …
India report record number of COVID deaths as bodies drift down Ganges
May 12, 2021Research and Development COVID-19, India, Indian COVID crisis, covid 19 news, covid-19 news, pharma, pharma news
India yesterday reported the country’s highest COVID-19 death total for a single day, with 4,205 fatalities officially confirmed.
Astellas prostate cancer drug gets third approval from MHRA
May 12, 2021Research and Development Astellas, MHRA, cancer research, cancer treatment, pharma, pharma news, prostate cancer
The MHRA has approved Astellas Pharma’s XTANDI (enzalutamide) drug for the treatment of a third form of prostate cancer, making …
NICE rejects Pfizer’s Vyndaqel for treating rare heart condition
May 12, 2021Research and Development NICE, Pfizer, Vyandaqel
NICE has published final guidance today which rejects tafamidis, also known as Vyndaqel, for treating rare heart condition transthyretin amyloidosis …
Endogena’s retinitis pigmentosa treatment granted Orphan Drug Designation by FDA
May 12, 2021Research and Development DFA, Endogena, Orphan Drug Designation
Endogena Therapeutics Inc has been granted Orphan Drug Designation for its EA-2353 ophthalmic suspension targeting retinitis pigmentosa by the FDA. …
Eli Lilly and MiNA Therapeutics to collaborate on saRNA research
May 12, 2021Research and Development Eli Lilly
Eli Lilly and MiNA Therapeutics have announced a global research collaboration to develop novel drug candidates using MiNA’s proprietary small …
Bayer’s cardiovascular drug shows impressive Phase III results
May 11, 2021Manufacturing and Production Bayer, chronic kidney disease, pharma, pharma news, type 2 diabetes
Bayer’s finerenone drug has been shown to significantly reduce cardiovascular death or other cardiovascular events in patients with chronic kidney …
Abbvie psoriatic arthritis drug approved for use in Scotland
May 11, 2021Manufacturing and Production AbbVie, NHS, arthritis, psoriatic arthritis
Abbvie’s RINVOQ (upadacitinib) drug, for the treatment of active psoriatic arthritis (PsA) in adults, has been approved for use in …
FDA authorizes use of Pfizer vaccine for children aged 12-15
May 11, 2021Manufacturing and Production COVID-19, FDA, Pfizer, Vaccine
The FDA announced it has expanded the emergency use of the Pfizer-BioNTech vaccine in children aged 12-15 yesterday.It was determined …
Facio Therapies announces AI collaboration for FSHD drug design
May 11, 2021Manufacturing and Production AI, drug discovery
Facio Therapies and Iktos have announced a collaboration to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of …
Biogen and Capsigen to collaborate on novel gene therapies
May 11, 2021Manufacturing and Production gene therapy
Biogen and Capsigen have announced a research collaboration to engineer novel adeno-associated virus (AAV) capsids that have the potential to …
Self-administered Crysvita receives positive CHMP opinion
May 10, 2021Sales and Marketing CHMP, EMA
Kyowa Kirin’s drug for a rare metabolic bone disease, Crysvita, has received a positive opinion from the EMA’s Committee for …
NICE rejects Merck Serono’s Bavencio for urothelial cancer
May 10, 2021Sales and Marketing MSD, Merck, NHS, NICE, cancer treatment, pharma, pharma news
The use of avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy is not recommended by …
EMA begin review of GSK & Vir COVID-19 treatment
May 10, 2021Sales and Marketing COVID-19, EMA, GSK, covid-19 treatment, pharma, pharma news, vir
The EMA has begun a rolling review of GSK and Vir’s sotrovimab treatment for COVID-19, which will continue until there …
Pfizer commences process for full FDA approval of COVID-19 vaccine
May 10, 2021Sales and Marketing BioNTech, COVID-19 vaccine, FDA, Pfizer, Pfizer vaccine, pharma, pharma news
Pfizer and BioNTech have begun a Biologics Licence Application (BLA) with the FDA for full approval of their mRNA COVID-19 …
Eli Lilly to collaborate with diabetes tech companies on insulin pen
May 10, 2021Sales and Marketing Eli Lilly, diabetes
Eli Lilly has signed strategic international agreements with four companies – Dexcom, Glooko, myDiabby Healthcare, and Roche – with the …
Pharmafile.com’s top 10 news stories of the week
May 7, 2021Medical Communications covid 19 news, covid-19 news, news round up, pharma, pharma news, top 10
Among our ten most-read stories this week: NICE has announced that more patients are eligible for a £75,000-a-vial SMA drug, …
Merck kidney and uterus cancer treatments granted priority review by FDA
May 7, 2021Medical Communications FDA, MSD, Merck, cancer treatment, kidney cancer treatment, pharma, pharma news, uterus cancer treatment
The FDA has granted priority review for Merck (MSD) and Eisai’s application for two new approvals for the combination of …
Deloitte acquires Iperion Life Sciences Consultancy
May 7, 2021Medical Communications marketing, sales
Deloitte have announced the acquisition of Iperion Life Sciences Consultancy, a globally-operating firm working to support life sciences companies and …
AstraZeneca secures MHRA licensing and NHS early access for lung cancer drug
May 7, 2021Medical Communications Astrazenaca, oncology
AstraZeneca have announced that the MHRA has granted a license extension for Tagrisso (osimertinib) in the UK, for use as …
Latest content
